S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Reitmans (Canada) Limited announces its results for the nine and three months ended November 2, 2013 (2013/12/3)|
|Ormat Sells Heber Solar PV Project for $35.25 Million (2014/3/26)|
|Trulia Releases Open Source Code to Spark Further Innovation in the Real Estate Industry (2014/2/18)|
|Reitmans (Canada) Limited - Normal course issuer bid (2013/12/16)|
|Reitmans (Canada) Limited announces its results for the six and three months ended August 3, 2013 ()|
|Reitmans (Canada) Limited reports December sales ()|
|TRADE NEWS: Agilent Technologies Expands Catalog of SureFISH Break-Apart Probes (2013/11/13)|
|Reitmans (Canada) Limited Announces Year-End Results (2014/4/2)|
|COMETRIQ® (cabozantinib) Receives Positive Opinion from European Committee for Medicinal Products for Human Use for Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma ()|
|Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Application for the Treatment of Radioactive Iodine-Refractory Differentiated Thyroid Cancer ()|
Click above to view more mutual fund data and stats for ret - Reitmans (Canada) Limited.